Cerebral palsy is a heterogeneous disorder of movement and posture caused by a non-progressive brain injury early in development. It presents with a wide variety of motor impairments and can be classified anatomically (e.g. hemiplegia) or physiologically (e.g. spastic, athetoid). Risk factors include prenatal, perinatal, and postnatal insults. Treatment involves both non-operative measures like medication, bracing, and physical therapy as well as operative interventions like tendon lengthening and osteotomies to prevent or treat deformities when they interfere with function. Prognosis depends on the extent and location of brain injury.
Still's disease, sometimes referred to as Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain and a distinctive salmon-colored bumpy rash.
NDT, BOBATH TECHNIQUE, BASIC IDEA OF BOBATH, CONCEPT OF BOBATH, NEUROPHYSIOLOGY OF NDT, ICF MODEL, PRINCIPLES OF TREATMENT OF NDT IN STROKE AND CP, AUTOMATIC AND EQUILIBRIUM REACTIONS, KEY POINTS OF CONTROL, FACILITATION, INHIBITION AND HANDLING IN NDT
FA is a very rare, genetic, recessive disease, affecting 1/50,000 people.
Originates from mutations in the “coding” of the mitochondria.
Discovered by Nicholaus Friedreich in the early 1860’s.
Both parents must have the dominant trait for a 25% chance of an offspring possessing the disease.
Not necessarily a disease that kills you, but eventually a wheelchair and regular assistance will be required.
Onset before age 20-25 year.
Still's disease, sometimes referred to as Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain and a distinctive salmon-colored bumpy rash.
NDT, BOBATH TECHNIQUE, BASIC IDEA OF BOBATH, CONCEPT OF BOBATH, NEUROPHYSIOLOGY OF NDT, ICF MODEL, PRINCIPLES OF TREATMENT OF NDT IN STROKE AND CP, AUTOMATIC AND EQUILIBRIUM REACTIONS, KEY POINTS OF CONTROL, FACILITATION, INHIBITION AND HANDLING IN NDT
FA is a very rare, genetic, recessive disease, affecting 1/50,000 people.
Originates from mutations in the “coding” of the mitochondria.
Discovered by Nicholaus Friedreich in the early 1860’s.
Both parents must have the dominant trait for a 25% chance of an offspring possessing the disease.
Not necessarily a disease that kills you, but eventually a wheelchair and regular assistance will be required.
Onset before age 20-25 year.
Spina bifida/ dysraphism - assessment and physiotherapy management Susan Jose
refrences kessler tecklin darcy.
a all round description of assesment in physiotherapeutic methods and management techniques.
participationn increasing measures and limitation reduction stratergies
Cerebral palsy for MBBS (undergraduate medical teaching)Siddhartha Sinha
This presentation gives an overview regarding Cerebral palsy. Its causes, pathogenesis , classification, clinical and examination findings and an overview of its orthopaedic management. Please feel free to drop in any doubts or queries regarding the presentation.
Holistic concept in treatment of Cerebral Palsy jitendra jain
it is very difficult to manage cerebral palsy because we cant repair brain damage but we can give good quality of independent life by combination good rehabilitation tool which include advance therapeutic technique, botulinum toxin early age child and SEMLOSSS surgical concept in others. Our aim of management is to take these person to their highest capability and decrease their physical limitation as much as possible. This ppt have brief review about latest concept in mx of cerebral aplsy
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. Definition
• Cerebral palsy is a heterogeneous disorder of
movement and posture that has a wide
variety of presentations, ranging from mildly
affected individuals who present with some
degree of motor disturbance to severely
affected patients who have total body
involvement.
3. Etiology
• CP is believed to occur due to insult to the
brain between the time of conception and age
of 2 years.
• Although it can occur anytime before the age
of 8 years.
• After the age of 8, most of the development of
the immature brain is complete, as is gait
development.
4. • Although the neurological deficit is permanent
and nonprogressive, the effect it can have on the
patient is dynamic, and the orthopaedic aspects
of cerebral palsy can change dramatically with
growth and development.
• Growth, along with altered muscle forces across
joints, can lead to progressive loss of motion,
contracture, and eventually joint subluxation or
dislocation, resulting in degeneration that may
require orthopaedic intervention.
9. Physiological
• Pyramidal type or spastic type
• Extrapyramidal type which include Athetoid,
Choreiform, Ataxic, Rigid and Hypotonic.
10. Spastic
• Most common
• Velocity-dependent increased muscle tone
and hyperreflexia with slow, restricted
movement due to simultaneous contraction of
agonist and antagonist muscles.
• Joint contractures, subluxtions and
degenrations are common in this type.
11. Athetoid
• Characterized by dyskinetic,(constant succession
of slow, writhing, involuntary, purposeless
movement) that may be exacerbated by
environmental stimulation.
• In pure athetoid cerebral palsy, joint contractures
are uncommon.
• Dystonia, characterized by increased overall tone
and distorted positioning in response to
voluntary movements, or hypotonia also can
occur with athetoid cerebral palsy.
12. Choreiform
• Characterized by continual purposeless
movements of the patient’s wrists, fingers,
toes, and ankles.
• This continuous movements can make bracing
and sitting difficult.
13. Rigid
• Patients with rigid cerebral palsy are the most
hypertonic of all cerebral palsy patients.
• This hypertonicity occurs in the absence of
hyperreflexia, spasticity, and clonus, which are
common in spastic cerebral palsy.
• These patients have a “cogwheel” or “lead
pipe” muscle stiffness that often requires
surgical release.
14. Ataxic
• Ataxic cerebral palsy is very rare and probably is
the most often misdiagnosed type.
• It is characterized by the disturbance of
coordinated movement, most commonly walking,
as a result of an injury to the developing
cerebellum.
• It is important to distinguish true ataxia from
spasticity because with treatment many children
with ataxia are able to improve their gait function
without surgery.
15. Hypotonic
• Hypotonic cerebral palsy is characterized by
weakness in conjunction with low muscle tone
and normal deep tendon reflexes.
• Many children who ultimately develop spastic or
ataxic cerebral palsy pass through a hypotonic
stage lasting 1 or 2 years before the true nature
of their brain injury becomes apparent.
• Persistent hypotonia can lead to difficulties with
sitting balance, head positioning, and
communication.
16. Mixed
• Many patients with cerebral palsy have
features of more than one type and are
referred to as having mixed cerebral palsy.
• Patients with mixed cerebral palsy usually
show signs of pyramidal and extrapyramidal
deficits.
• The final clinical appearance is determined by
the relative components of spasticity,
athetosis, and ataxia.
17. • No one system is optimal for the classification
and description of patients with cerebral palsy
because of their heterogeneity.
• Because many patients exhibit variable patterns
of motor activity that do not fit completely into
one category or another, an individualized
approach should be used for each patient.
• Palisano et al. developed the Gross Motor
Function Classification System to help resolve
these classification difficulties
18. Gross Motor Function Classification System
• I - Has nearly normal gross motor function
• II - Walks independently, but has limitations with
running and jumping
• III - Uses assistive devices to walk and wheelchair for
long distances
• IV - Has ability to stand for transfers, but minimal
walking ability; depends on wheelchair for mobility
• V - Lacks head control, cannot sit independently, is
dependent for all aspects of care
20. Early signs
• Stiff or floppy posture.
• Excessive lethergy or irritability/ high pitched
cry
• Poor head control.
• Week suck/tongue thrust/tonic bite/feeding
difficulties
21. Physical examination
• It mainly consists of 7 main points
1. Strength and selective motor control of isolated
muscle.
2. Degree and type of muscle tone.
3. Degree of static muscle and joint contracture.
4. Torsional and other bone deformities.
5. Fixed mobile foot deformities.
6. Balance, equilibrium responses and standing
posture.
7. Gait by observation.
23. Observational gait analysis
• Beginning from the feet the following points must be
considered
- Position of the foot at the end of terminal swing
- Position of ankle
- Foot progression during stance and swing; position of
foot in stance phase.
- Alignment of forefoot with hindfoot; arch of foot; point
of gait cycle where deviation occurs from normal;
position of toes in swing and stance phases
- At knee, position of knee in terminal swing and initial
contact; max degree of flexion at in swing; varus/valgus
during stance.
24. • At pelvis; hip and trunk alignment of thigh to
line of progression, hip extension in terminal
stance; excessive
abduction/adduction(scissoring) in swing
phase, pelvis obliqutiy.
• Trunk movements in each plane, movement of
arms and wether child elevates his/her hands
for balance.
25. Computerized gait analysis
• Observational is more difficult proximally
where large muscles obscure hips and pelvis.
• Computerized gait analysis is helpful in
determining any deviations in these joints.
26. • Some common gait patterns in spastic diplegia
cp include:
• Jump-knee gait
• Toe-toe gait pattern
• Crouch gait
• Stiff knee gait
• Rotational deformities that affect gait (femoral
anteversion and tibial torsion)
27.
28. Prognostic factors
• Poor prognostic signs for walking reported by Bleck
included
• (1) an imposable asymmetrical tonic neck reflex,
• (2) persistent Moro reflex,
• (3) strong extensor thrust on vertical suspension,
• (4) persistent neck-righting reflex, and
• (5) absence of normal parachute reflex after 11 months.
• The persistence of these primitive reflexes is associated
with extensive and severe brain damage and a poor
prognosis for independent ambulation, self-care, and
activities of daily living.
29. Associated conditions
• Mental impairment or learning disability
(40%)
• Seizures (30%)
• Complex movement disorders (20%)
• Visual impairment (16%)
• Malnutrition and related conditions like
GERD(15%)
• Hydrocephalus (14%)
33. • Diazepam acts by facilitating transmission at the
inhibitory synopsis in the CNS called GABBA
receptors.
• Reduces mono and poly-synaptic reflexes
resulting in increased inhibition, there by
reducing the spasticity.
• Acts both on brain and spinal chord.
• Most common Side effect is sedation and develop
tolerance or dependence.
• Dosage – 0.12 to 0.8 mg/kg/day
34. • Baclofan is a structural analog of GABBA and
binds to GABBAb receptors resulting in
inhibition of mom and poly-synaptic reflexes.
• Acts mainly on spinal chord.
• Reduces spasticity, hyperreflexia and clonus.
• Dosage – 2.5mg – 10mg/day upto 40mg a day
in divided doses.
35. • Baclofan has a poor BB barrier penetration
and has short half-life (3-4hrs)
• Hence requires gradual titration and use of
extremely high systemic levels to obtain a
central effect of spasticity reduction.
• Intrathecal injection requires 1/30 the dose of
oral baclofan to achieve same result.
36. • Implantable programmable pump is used in
injecting balofan intrathecally.
• Implanted subcutaneously in abdominal wall.
• Refill in 2-3months.
37. • Dantrolene sodium acts at the site of skeletal
muscles as opposed to other drugs which act
on the neurotransmitter system.
• It acts by inhibiting the release of calcium ions
from sarcoplasmic retinaculium during muscle
contractions.
• Reduces clonus and muscle spasms.
• Dosage – 6-8mg/kg/day in divided doses.
38. • Botulinum toxin is an effective synaptic blocker
which acts on inhibition of release of
acetylcholine at the presynaptic junction.
• Produced by clostridium botulinum.
• Two serotypes available in market A and B.
• A – BOTOX, B – MYOBLOC.
• Effects are reversible hence required every 2-
3months
• Dosage – 10-12U/kg but not > 400U
39. Splinting and bracing
• Bracing in patients with cerebral palsy most
commonly is used to prevent or slow
progression of deformity.
• The most commonly used braces for the
treatment of cp include AFO, hip abduction
braces, hand and wrist splints and spinal
braces or jackets.
40.
41. Operative treatment
• Indicated when contractures or deformities
decrease function, cause pain, or interfere
with activities of daily living.
• It is the only effective treatment when
significant fixed contractures exist.
• Should be scheduled to minimize the number
of hospitalizations and interference with
school and social activities.
42. • “Birthday surgery” or multiple procedures
performed at different times, as described by
Rang, should be avoided whenever possible.
• The use of single-event multilevel surgery has
been shown to improve both upper and lower
extremity function as well as quality of life
while minimizing a patient’s exposure to
repeated hospitalizations and rehabilitation.
43.
44. NEUROSURGICAL INTERVENTION
• Selective dorsal root rhizotomy is a technique to reduce
spasticity and balance muscle tone in carefully selected
patients.
• In patients with cerebral palsy, the normal central nervous
system inhibitory control of the gamma efferent system is
deficient, leading to the exaggerated stretch reflex
response.
• Goal is to identify the rootlets carrying excessive
stimulatory information and section them to reduce the
stimulatory input from the dorsal sensory fibers.
• The ideal patient - 3 to 8 years old with spastic diplegia,
voluntary motor and trunk control, pure spasticity, and no
fixed contractures.
46. Hip
• In most patients, the hip is normal at birth and
radiographic changes typically become apparent
between 2 and 4 years of age.
• The cause of this progressive deformity is multifactorial
and includes muscle imbalance, retained primitive
reflexes, abnormal positioning, and pelvic obliquity.
• These altered forces across the hip along with
decreased weight bearing lead to bony deformities,
including acetabular dysplasia, excessive femoral
anteversion, increased neck-shaft angle, and
osteopenia.
49. Adduction deformity at hip
• Most common in cp
• This can cause various deformities like
scissoring gait, hip subluxations.
• Surgery- adductor tenotomy
and release.
Indicated in mild contractures and
should be done as early before 4yrs
can be done till 8yrs.
51. Varus derotational osteotomy
• Indicated for patients with excessive
anteversion and valgus deformity of the
proximal femur and a hip that is either
subluxated or dislocated.
• Resection arthroplasty, arthrodesis, THA are
proposed in painful dislocated hip when a
relocation procedure is not possible.
54. Knee
• Deformities of the knee in patients with cerebral palsy are
difficult to evaluate and treat and rarely occur in isolation.
• Pelvic, hip, knee, ankle, and foot deformities are
interrelated. The hip and the knee are tightly coupled
because of the muscles that cross both joints, the “two-
joint muscles.”
• Pathological conditions that affect these muscles, such as
spasticity or contracture, and surgical changes affect the
function of both joints.
• Hence a careful physical examination of the entire lower
extremity is essential when evaluating the knee in patients
with cerebral palsy.
55. • Commonly seen deformities at knee are
1. Felxion deformity
2. Recurvatum of knee
3. Knee valgus
4. Patella alta
56. Flexion deformity of knee
• Knee flexion deformities keep the knee from
fully extending at the end of the swing phase
of gait.
• This causes the knee to be flexed during
stance phase, leading to decreased stride
length and increased energy expenditure
• Can result from hip or ankle pathology.
57. • Patients with spastic hip flexors or weak hip
extensors or both develop compensatory knee
flexion that results in crouch gait in which the
hips, knees, and ankles are flexed.
• To find the source of the knee flexion, the
muscles must be assessed to determine if the
deformity is caused by spasticity or
contracture or both.